Using the behaviour change technique taxonomy v1 (BCTTv1) to identify the active ingredients of pharmacist interventions to improve non-hospitalised patient health outcomes by Scott, Claire et al.
1Scott C, et al. BMJ Open 2020;10:e036500. doi:10.1136/bmjopen-2019-036500
Open access 
Using the behaviour change technique 
taxonomy v1 (BCTTv1) to identify the 
active ingredients of pharmacist 
interventions to improve non- 
hospitalised patient health outcomes
Claire Scott   ,1 Mícheál de Barra   ,2 Marie Johnston,3 Marijn de Bruin,3,4 
Neil Scott,5 Catriona Matheson,6 Christine Bond,7 Margaret C Watson8
To cite: Scott C, de Barra M, 
Johnston M, et al.  Using the 
behaviour change technique 
taxonomy v1 (BCTTv1) to 
identify the active ingredients 
of pharmacist interventions to 
improve non- hospitalised patient 
health outcomes. BMJ Open 
2020;10:e036500. doi:10.1136/
bmjopen-2019-036500
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
036500).
Received 06 January 2020
Revised 15 July 2020
Accepted 14 August 2020
For numbered affiliations see 
end of article.
Correspondence to
Claire Scott;  
 claire. scott@ nes. scot. nhs. uk
Original research
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Objectives The aim of this study was to identify which 
behaviour change techniques (BCTs) were present in 
intervention and control groups of randomised controlled 
trials (RCTs) included in a Cochrane systematic review.
Setting The RCTs included were conducted in community, 
primary and/or ambulatory- care settings.
Participants The data set was derived from 86 RCTs 
from an interim update of the Cochrane review of the 
effectiveness of pharmacist services on non- hospitalised 
patient outcomes.
Primary and secondary outcome measures The 
primary outcome was the identification of BCTs scheduled 
for delivery in intervention and control groups of the RCTs. 
The secondary outcome measure was to identify which 
BCTs are not being utilised in intervention and control 
groups of the RCTs.
Results The intervention and control groups included 
31 and 12 BCTs, respectively. The number of identifiable 
BCTs/study ranged from 0 to 12 in the intervention groups 
(mean 3.01 (SD 2.4)) and 0 to 6 in the control groups 
(mean 0.38 (SD 0.84)). The most commonly identified 
BCTs in the intervention groups were: instruction on how 
to perform the behaviour (55%, n=47) (also the most 
common BCT in control groups); problem solving (29%, 
n=25); information about health consequences (24%, 
n=21); social support (practical) (24%, n=21); and social 
support (unspecified) (23%, n=20) (the second most 
common BCT in control groups). Thirteen trials had no 
identifiable BCTs in either group.
Conclusion The pharmacist interventions presented in 
this study did not use the full range of available BCTs. 
Furthermore, the reporting of BCTs was incomplete for 
both intervention and control groups, thereby limiting 
the utility and reproducibility of the interventions. Future 
interventions should be designed and reported using 
relevant taxonomies and checklists for example, BCT 
taxonomy and TIDieR (the template for intervention 
description and replication).
BACKGROUND
Behaviour change interventions tend to 
be complex and consist of many different 
active ingredients working within the one 
intervention.1 It can therefore be difficult 
to pinpoint the individual active ingredi-
ents that are being used in order to change 
behaviour. It is vital that these are identi-
fiable for transparency, implementation, 
literature synthesis and future research. 
For example, a randomised controlled trial 
(RCT) to evaluate the effectiveness of a 
medicine will specify the active ingredient(s) 
of the test drug, together with the strength, 
dose, frequency and duration, in order for 
the evaluation to be comprehensible and 
replicable. If trial authors simply stated that 
a white pill was being tested, this information 
and the trial itself would be useless due to 
the lack of detailed information. The latter 
scenario reflects the level of specification of 
the behaviour change intervention in many 
trials which evaluate their effectiveness. All 
the active ingredients of a behaviour change 
Strengths and limitations of this study
 ► This study was able to identify behaviour change 
techniques (BCTs) used, as well as those not used, 
in randomised controlled trials of pharmacist inter-
ventions (and control groups).
 ► There was a high level of agreement between the 
coders using the BCT taxonomy v1 (BCTTv1).
 ► The accuracy of the BCT coding was reliant on the 
information provided in the studies and supple-
mentary materials, which was not always detailed 
enough to give an accurate description of each in-
tervention and control group.
 ► This study helps to emphasise the need for con-
sistent reporting of BCTs in studies of pharmacist 
interventions (and control groups) to inform future 
developments.
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intervention should be clearly defined and reported to 
enable their replication.
The behaviour change technique taxonomy v1 
(BCTTv1)2 was developed to provide a shared, stan-
dardised terminology to be used to specify the active 
ingredients of behaviour change interventions, that is 
BCTs.3 The BCTTv1 is a reliable taxonomy which consists 
of 93 unique BCTs that are categorised into 16 groups. 
Each BCT has its own number pertaining to its group and 
position within that group. BCTs are the ‘active ingredi-
ents’ of a behaviour change intervention. They are observ-
able, replicable and irreducible.4 These BCTs are specific, 
each with their own individual label and definition that 
can be used when designing and reporting interventions, 
but also when coding interventions for their content.
Several systematic reviews with meta- regression found that 
interventions that contain certain BCTs are more effective 
than interventions without that BCT, for example, action 
planning to enhance physical activity; self- monitoring and 
providing instruction for weight loss in obese adults;5 self- 
monitoring to increase physical activity and healthy eating.6
The BCT taxonomy is a promising tool for phar-
macist interventions. Intervening to enable clients to 
change self- management behaviours has become part 
of the changing role of pharmacists in recent years, 
as well as more traditional dispensing role. Additional 
behavioural and clinical activities taken on by pharma-
cists include medication review,7 adherence support8 
and advising practitioners on their prescribing,9 as well 
as enhanced roles in public health.10 11 The pharmacist 
is therefore becoming an ever more important figure in 
public health, particularly through their implementa-
tion of behaviour change interventions.
The impact of pharmacists’ non- dispensing roles was 
reviewed by Nkansah et al9 in a Cochrane systematic 
review which found that pharmacist interventions, in 
general, lead to improved clinical outcomes, therefore 
supporting the role of pharmacists in behaviour change 
interventions. However, when that review was published, 
the BCTTv1 had not been developed and the under-
pinning behavioural techniques used within interven-
tions were not reported. Investigating which BCTs are 
used and which are associated with improved outcomes 
can advance both research and practice in this area by 
allowing links to theoretical frameworks and by providing 
additional information about methods that might be 
implemented in practice to enhance effectiveness.
Furthermore, while the previous review was able to 
make comparisons between outcomes in intervention 
and control groups in RCTs, it did not report the support 
given to participants in the control groups as part of ‘stan-
dard care’ or ‘treatment as usual’. Given that the size of 
effect of a trialled intervention will be affected by the 
practice in the control group, it is important to attempt 
to specify any BCTs delivered in both groups.12 13
This current study stems from an interim update of the 
Cochrane systematic review.14 The aim of the current study 
was to identify the BCTs evaluated in the intervention and 
control groups reported in RCTs included in the system-
atic review. The primary outcome was to identify the 
BCTs scheduled for delivery in intervention and control 
groups of the RCTs. The secondary outcome measure was 
to identify which BCTs are not being utilised in the inter-
vention and control groups of the RCTs.
METHODS
Design and study selection
The data set for this current study comprised the 86 
studies included in the interim update of the Cochrane 
systematic review.14 The studies were RCTs of pharma-
cist interventions to improve non- hospitalised patient 
outcomes and were published between October 1979 and 
January 2015. (The review was further updated in January 
2018. This current study is based solely on the 86 studies 
in the interim version of the review.) BCTs were identified 
and coded in both intervention and control groups.
Behaviour change technique coding
Authors of the 86 included studies were contacted 
where possible via email to request additional mate-
rials such as protocols and study materials. Two 
reviewers (CS and MdBa) underwent training in BCT 
coding using an online training tool.15 Coding using 
BCTTv12 was piloted with five studies taken from the 
excluded studies of the review to compare and refine 
the coding process. For all the included studies, the 
behaviour change intervention in both the intervention 
and control groups was independently coded by both 
authors using the BCTTv1. Discrepancies were resolved 
by discussion and, if necessary, a third trained coder 
(MJ) made the final decision.
Data analysis
Inter- rater reliability of the coding was calculated 
using Cohen’s kappa adjusted for prevalence and bias 
(PABAK).16 PABAK is a measure of inter- rater agreement 
which controls for chance agreement and which is partic-
ularly useful in situations where there are high levels of 
negative agreement as is often found in coding BCTs that 
is, when both coders agree that a BCT is absent. To assess 
the primary outcome, the frequency of BCTs used in both 
the intervention and control groups was calculated and 
reported. To assess the secondary outcome, BCTs not 
utilised in either the intervention or control group of any 
study were identified and reported.
Patient and public involvement
This research was done without patient involvement. 
Patients were not invited to comment on the study design 
and were not consulted to develop patient- relevant 
outcomes or interpret the results. Patients were not 
invited to contribute to the writing or editing of this docu-
ment for readability or accuracy.
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RESULTS
An email response was received from authors of 47 studies 
and relevant responses were received from 32, who 
provided additional materials associated with the content 
or delivery of their intervention in both intervention 
and/or control groups. The overall inter- rater reliability 
for BCT coding of all 86 studies was high, PABAK=0.94.
Of the 86 studies coded for BCTs, at least one BCT could 
be identified and coded in 73 intervention descriptions. 
Within intervention groups, the number of identifiable 
BCTs per study ranged from 0 to 12 (median 3 (IQR: 1 to 
4), mean 3.01 (SD: 2.4)). In control groups, at least one 
BCT could be identified and coded in 23 of the 86 studies 
and the number of identifiable BCTs per study ranged from 
0 to 6, (median 0 (IQR: 0 to 1), mean 0.38 (SD: 0.84)).
Which BCTs were used?
Thirty- one of the possible 93 BCTs in the BCTTv1 were 
identified (figure 1). All 31 were used in intervention 
groups and 12 of these were delivered to control groups. 
Each BCT was used more often with intervention than with 
control groups. The most commonly identified BCTs for 
the intervention groups were: 4.1 instruction on how to 
perform the behaviour (54.7% of all intervention descrip-
tions included this BCT), 1.2 problem solving (29.1%), 5.1 
information about health consequences (24.4%), 3.2 social 
support (practical) (24.4%) and 3.1 social support (unspec-
ified) (23.3%) (figure 2).
The most commonly identified BCTs in the control groups 
were: 4.1 instruction on how to perform the behaviour 
(11.6% of all control descriptions included this BCT) and 
3.1 social support (unspecified) (8.1%) (figure 3).
Of the 93 BCTs in the BCTTv1, 62 were not identified in 
any intervention or control group description. Of the 16 
groups of BCTs within the BCTTv1, 10 were identifiable in 
the coded studies represented in bold table 1 (figures 2 and 
3 display the individual BCTs colour coded by their BCT 
grouping); six groups of BCTs were not represented in any 
study (table 1).
Thirteen studies had no identifiable BCT in either their 
intervention or control descriptions. Eight of these RCTs 
reported a positive intervention effect on at least one of the 
outcome measures.
Figure 1 Number of studies reporting each BCT in 
intervention and control group descriptions. BCT, behaviour 
change technique.
 
0 5 10 15 20 25 30 35 40 45 50
1.1.  Goal setting (behaviour)
1.2.  Problem solving
1.3.  Goal setting (outcome)
1.4.  Action planning
1.5.  Review behaviour goal(s)
1.7.  Review outcome goal(s)
1.8.  Behavioural contract
2.1. Monitoring of behaviour by others without feedback
2.2. Feedback on behaviour
2.3. Self-monitoring of behaviour
2.4. Self-monitoring of outcome(s) of behaviour
2.5. Monitoring of outcome(s) of behaviour without feedback
2.6. Biofeedback
2.7. Feedback on outcome(s) of behaviour
3.1. Social support (unspecified)
3.2. Social support (practical)
3.3. Social support (emotional)
4.1. Instruction on how to perform the behaviour
4.4. Behavioural experiments
5.1. Information about health consequences
6.1. Demonstration of the behaviour
6.2. Social comparison
7.1. Prompts/cues
8.1. Behavioural practice/rehearsal
8.2. Behaviour substitution
8.3. Habit formation
11.1. Pharmacological support
11.2. Reduce negative emotions
12.1. Restructuring the physical environment
12.2. Restructuring the social environment
12.5. Adding objects to the environment
Number of studies in which the BCT was identified
Identified BCTs in Intervention groups
Colour coded by BCT Taxonomy (v1) grouping
Figure 2 BCTs in intervention group descriptions. BCT, 
behaviour change technique.
Figure 3 BCTs in control group descriptions. BCT, 
behaviour change technique.
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DISCUSSION
Several BCTs were commonly used in pharmacy inter-
ventions such as ‘instruction on how to perform the 
behaviour’, ‘problem solving’, ‘information about health 
consequences’, ‘social support (practical)’ and ‘social 
support (unspecified)’. Additionally, the control groups 
included a number of identifiable BCTs. Of the 93 BCTs 
in the BCTTv1, 31 were found across the 86 included 
studies, 19 of which were unique to the intervention 
groups.
Some of the BCTs that were frequently implemented 
have been found to be effective in previous research. 
‘Instruction on how to perform the behaviour’ was 
identified in the intervention groups of 47 out of the 
86 studies and was by far the most prominent BCT 
found in this review. This BCT has been effective in 
interventions for physical activity in inactive adults17 
and diet and physical activity interventions in Type II 
diabetes, particularly for the reduction of haemoglobin 
A1c.18 This was also the most common BCT identified 
in control groups (10 of the 86 studies). The BCT, 
‘social support (unspecified)’, was identified in the 
intervention groups of 20 out of the 86 studies. It was 
also the second most reported BCT in control groups, 
appearing in seven of the 86 studies. This BCT has been 
effective in physical activity interventions for people 
with dementia.19
Only 31 of the 93 available BCTs from 10 of the 16 
groups were represented in the 86 studies. This means 
that 62 BCTs and six of the 16 BCT groupings were 
not used (or were used but were not identifiable from 
the reporting) in any of the interventions. While some 
BCTs may not be suitable for implementation in all 
pharmacist interventions, it is evident that the majority 
(67%) of BCTs available are not being tested at all in 
these types of interventions. There is, therefore, the 
possibility to expand the types of active ingredients in 
pharmacist interventions explored in future studies.
Some control groups reported BCTs that could, in 
theory, alter behaviour; as such, this needs to be taken 
into consideration when interpreting results from trials 
where BCTs appear in both intervention and control 
groups, potentially altering the apparent effect size 
of the intervention. If there is incomplete descrip-
tion of control group conditions, more BCTs might be 
present than reported, and as such, may affect the study 
outcomes.12 13 20
It is worth noting that 13 RCT interventions had no 
identifiable BCTs and yet eight of these studies reported 
an intervention effect. While this might suggest that these 
interventions contained BCTs not currently included in 
the BCTTv1, it is more likely that BCTs were included 
but not reported, thus giving a misleading picture of the 
intervention. Overall, reporting of the content of inter-
ventions was unclear, vague and incomplete, even with 
the aid of additional materials.
Several BCTs that have previously been found to be 
effective in behaviour change interventions were used 
infrequently in pharmacist interventions, suggesting 
that opportunities for effective intervention may be 
being missed. ‘Action planning’ was only identified 
in 11 studies despite growing evidence of its effective-
ness.17 18 21 ‘Goal setting (behaviour)’ and ‘goal setting 
(outcome)’ are effective in behaviour change interven-
tions19 22 23 but were identifiable in six and 15 studies, 
respectively. Similarly, ‘self- monitoring (behaviour)’ 
and ‘self- monitoring (outcome)’ were identifiable in 
five and 14 studies, respectively, despite considerable 
evidence of their effectiveness as BCTs.22–24 In addition, 
despite evidence of the effectiveness of ‘demonstration 
of behaviour’, 18‘behavioural practice/rehearsal’,17 18 
‘biofeedback’17 and ‘feedback’,22 they are seldom iden-
tifiable in the 86 RCTs. These BCTs may lack relevance 
to pharmacist- related activities or this finding may illus-
trate the need for a more explicit theory- based and 
evidence- based approach to designing pharmacist inter-
ventions and deciding which BCTs to include in them.
Poor reporting of interventions is a serious problem, 
highlighted by Hoffmann and colleagues.25 If inter-
vention descriptions are incomplete, then effective 
interventions cannot be reliably implemented, repli-
cated or synthesised, resulting in a serious waste of 
research effort and funding. Reporting of trials of 
non- pharmacological interventions has been found to 
lack detail and to continue to be incomplete even after 
contacting authors.26 Furthermore, analysis of titles 
and abstracts has demonstrated that the reporting of 
behavioural interventions has been found to be poorer 
than the reporting of other non- pharmacological inter-
ventions, a significant problem when this is the infor-
mation typically used to identify papers for evidence 
synthesis.27 The studies in the current paper were 
assessed using the template for intervention descrip-
tion and replication (TIDieR) checklist25 and most were 
found to lack adequate intervention reporting (full 
results reported elsewhere28); however, should future 
Table 1 BCT groupings (n=16)
Groupings in BCTTv1
1. Goals and planning* 9. Comparison of outcomes
2. Feedback and 
monitoring*
10. Reward and threat
3. Social support* 11. Regulation*
4. Shaping knowledge* 12. Antecedents*
5. Natural consequences* 13. Identity
6. Comparison of 
behaviour*
14. Scheduled consequences
7. Associations* 15. Self- belief
8. Repetition and 
substitution*
16. Covert learning
*BCT groupings represented in intervention or control group 
descriptions.
BCTTv1, behaviour change technique taxonomy v1.
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studies use the TIDieR checklist, the quality of inter-
vention reporting should improve.
There were both strengths and limitations to this study. 
A high level of agreement was achieved between coders 
and their application of the BCTTv1. The accuracy of the 
BCT coding was heavily reliant on, and therefore limited 
by, the information provided in the studies. While addi-
tional materials were sought from the authors, these were 
not always provided and/or were not always presented in 
sufficient detail to give an accurate description of what 
was being evaluated. The BCT coding study was under-
taken with the 86 studies included in the interim update 
of the Cochrane review and not the fully updated version 
of the review which comprised 116 studies.
CONCLUSION
A large number of BCTs have been evaluated in phar-
macy interventions. The coding of BCTs was affected by 
poor reporting. More transparent and comprehensive 
reporting of intervention and control groups would facil-
itate the identification of BCTs and the exploration of the 
association between individual BCTs and the effectiveness 
of interventions.
Future pharmacist interventions should be informed 
by the evidence of effective BCTs. Trials to evaluate these 
interventions should report the content of intervention 
and control groups using the BCTTv1 and TIDieR. This 
ultimately could help identify which specific behavioural 
interventions are most effective, specifically within the 
pharmacy setting.
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